By Megan Redshaw A panel of experts advising the U.S. Food and Drug Administration (FDA) on Tuesday voted to recommend Merck’s experimental antiviral pill used to treat COVID-19 for…
Pharmaessentia announced the U.S FDA has approved Besremi (ropeginterferon alfa-2b-njft) for the treatment of adults with polycythemia vera (PV). Besremi is a monopegylated, long-acting interferon…
Mirum Pharmaceuticals announced the U.S FDA has approved Livmarli (maralixibat) oral solution for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) one year of age…
By Steve Kirsch Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. Recently, both the…
Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite. Joel S. Hirschhorn It is tempting…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
